Bank of New York Mellon Corp - ONCOSEC MED INC ownership

ONCOSEC MED INC's ticker is ONCSXXXX and the CUSIP is 68234L207. A total of 1 filers reported holding ONCOSEC MED INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q1 2019$30,000
-53.1%
53,513
-46.7%
0.00%
Q4 2018$64,000
+166.7%
100,325
+484.1%
0.00%
Q3 2018$24,0000.0%17,1750.0%0.00%
Q2 2018$24,000
-25.0%
17,1750.0%0.00%
Q1 2018$32,000
+77.8%
17,175
+58.8%
0.00%
Q4 2017$18,000
+80.0%
10,816
+4.7%
0.00%
Q3 2017$10,000
-28.6%
10,331
-11.8%
0.00%
Q2 2017$14,000
-6.7%
11,717
+3.2%
0.00%
Q1 2017$15,0000.0%11,356
-1.2%
0.00%
Q4 2016$15,000
-21.1%
11,497
+5.6%
0.00%
Q3 2016$19,000
-24.0%
10,889
-28.9%
0.00%
Q2 2016$25,000
-24.2%
15,315
+18.6%
0.00%
Q1 2016$33,000
-2.9%
12,917
-7.9%
0.00%
Q4 2015$34,000
-49.3%
14,029
+8.6%
0.00%
Q3 2015$67,00012,9170.00%
Other shareholders
ONCOSEC MED INC shareholders Q2 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 340,169$1,752,0000.07%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 11,250$58,0000.02%
Mount Lucas Management LP 9,000$46,0000.01%
EDMOND DE ROTHSCHILD HOLDING S.A. 11,250$58,0000.00%
TCI Wealth Advisors, Inc. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 2,675$14,0000.00%
NORTHERN TRUST CORP 15,426$79,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 57,031$293,0000.00%
BlackRock Investment Management, LLC 2,633$14,0000.00%
CITIGROUP INC 1,000$5,0000.00%
View complete list of ONCOSEC MED INC shareholders